Ms. Vergis has over 35 years of experience in the healthcare industry and recently served as an executive advisor to private equity firms from 2013 to 2019. Prior to her advisory role she was the Chief Executive Officer of OraPharma, lnc., a privately held, specialty pharmaceutical company focusing on oral health. In that role she led the turnaround of the business and its subsequent successful sale. Preceding her role at OraPharma, Ms. Vergis managed a multi-billion portfolio at Johnson & Johnson as President of Janssen Pharmaceuticals, McNeil Pediatrics, and Ortho-McNeil Neurologics. Ms. Vergis contributed to several Johnson & Johnson companies during her career, serving as a member of company management boards for over 10 years and holding positions of increasing responsibility in research and development, new product development, sales, and marketing. Ms. Vergis serves on the Board of Directors for Church and Dwight Co., Inc., Teva Pharmaceutical Industries Ltd., and SGS SA. Ms. Vergis earned a B.S. degree in Biology and an M.S. degree in Physiology from The Pennsylvania State University. Director since 2019 Independent Age: 61 Board Committees: Science and Technology Committee (Chair) Compensation & Human Capital Committee Other Public Company Boards: Church & Dwight Co., Inc. SGS SA Teva Pharmaceutical Industries Ltd. Selected Key Qualifications and Experience: Large Company Experience as Executive or Board Member Ms. Vergis has significant business experience, including leadership roles as an executive. Medical Device or Industry Experience Ms. Vergis has worked for over three decades in the dental industry and the global healthcare field, including in various key advisory and executive positions. Capital Allocation/Deployment Experience Ms. Vergis has a substantial record of financial experience and proper maintenance of a large corporation, including an extensive history working with large transactions and business transformations.